Arcutis Biotherapeutics, Inc. (ARQT) income statement
ARQTNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 11/30413% above fair value
$26.36−0.81 (-2.98%)
Close on Nov 20, 2026Market cap $3.31BP/E 119.8Yield –
Arcutis Biotherapeutics, Inc. financial ratios
See a number that looks wrong?